her-vaxx study investigator, dr marina maglakelidze
Published 5 years ago • 805 plays • Length 2:24Download video MP4
Download video MP3
Similar videos
-
5:45
dr marina maglakelidze presents her-vaxx trial data at esmo 2019
-
5:30
imugene releases final data from phase 2 her vaxx study
-
4:49
imugene her-vaxx video asx: imu | an emerging leader in cancer immuno-oncology
-
6:29
imugene finishes phase 1a monotherapy dose escalation of pd1 vaxx
-
3:15
imugene's her-vaxx immunotherapy treatment: explained
-
9:07
juststocks speaks with imugene ceo and cf33 inventor on latest with company's clinical trials
-
38:07
covid-19 and the risk of cardiac issues (israeli, us, and german studies)
-
13:40
breakthrough therapy entering clinical trials. cancer killing virus by imugene is sheer genius!!
-
4:03
imugene doses first patient in phase-two study of cancer vaccine
-
4:27
imugene pd1 vaxx 1080p
-
4:45
imugene thrilled with ethics approval for phase 2 her-vaxx trial
-
6:15
imugene ceo hails clinical milestone for her-vaxx cancer immunotherapy
-
8:59
imugene officially announce their her-vaxx trial results
-
5:42
july 8 2019 her-vaxx esmo interview | proactive investors
-
0:37
imugene's science series: pd1-vaxx (intro)
-
5:39
imugene announces clinical trial supply agreement with merck kgaa and pfizer for her-vaxx
-
6:40
imugene doses first patient in vaxinia phase 1 trial
-
6:12
imugene @ aacr 2020: pd1-vaxx (imu-201) phase 1 briefing